Clinical Trial Update: Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN) [Phase 4]

View source ↗

Summary

Phase IV trial EVERGREEN evaluating the effect of evogliptin on blood glucose in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type2 Diabetes | Phase 4 | Status: COMPLETED